Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Lanini

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Ebiomedicine|August 23, 2024
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona)Valentina Mazzotta, Silvia Nozza, Simone Lanini, et al.
The Lancet. Infectious Diseases|April 11, 2026
Mpox virus in human breastmilk and tecovirimat pharmacokinetics: implications for postnatal transmissionFrancesca Colavita, Massimo Tempestilli, Silvia Meschi, et al.
Frontiers in Immunology|May 6, 2022
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19Valentina Mazzotta, Alessandro Cozzi-Lepri, Francesca Colavita, et al.
The Lancet. Infectious Diseases|August 2, 2015
Ebola: missed opportunities for Europe-Africa researchGiuseppe Ippolito, Simone Lanini, Philippe Brouqui, et al.
Vaccines|December 23, 2023
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIVAlessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Nature Communications|April 28, 2022
Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injectionSimone Lanini, Stefano Milleri, Emanuele Andreano, et al.
Journal of Clinical Medicine|August 7, 2021
Benefits of Steroid Therapy in COVID-19 Patients with Different PaO<sub>2</sub>/FiO<sub>2</sub> Ratio at AdmissionSerena Vita, Daniele Centanni, Simone Lanini, et al.
BMC Infectious Diseases|May 18, 2018
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort studySimone Lanini, Paola Scognamiglio, Alessandra Mecozzi, et al.
The Journal of Infection|September 29, 2024
Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron wavesValentina Mazzotta, Fulvia Mazzaferri, Simone Lanini, et al.
Journal of Medical Virology|October 3, 2022
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agentsValentina Mazzotta, Alessandro Cozzi Lepri, Francesca Colavita, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Ebiomedicine|August 23, 2024
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona)Valentina Mazzotta, Silvia Nozza, Simone Lanini, et al.
The Lancet. Infectious Diseases|April 11, 2026
Mpox virus in human breastmilk and tecovirimat pharmacokinetics: implications for postnatal transmissionFrancesca Colavita, Massimo Tempestilli, Silvia Meschi, et al.
Frontiers in Immunology|May 6, 2022
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19Valentina Mazzotta, Alessandro Cozzi-Lepri, Francesca Colavita, et al.
The Lancet. Infectious Diseases|August 2, 2015
Ebola: missed opportunities for Europe-Africa researchGiuseppe Ippolito, Simone Lanini, Philippe Brouqui, et al.
Vaccines|December 23, 2023
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIVAlessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Nature Communications|April 28, 2022
Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injectionSimone Lanini, Stefano Milleri, Emanuele Andreano, et al.
Journal of Clinical Medicine|August 7, 2021
Benefits of Steroid Therapy in COVID-19 Patients with Different PaO<sub>2</sub>/FiO<sub>2</sub> Ratio at AdmissionSerena Vita, Daniele Centanni, Simone Lanini, et al.
BMC Infectious Diseases|May 18, 2018
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort studySimone Lanini, Paola Scognamiglio, Alessandra Mecozzi, et al.
The Journal of Infection|September 29, 2024
Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron wavesValentina Mazzotta, Fulvia Mazzaferri, Simone Lanini, et al.
Journal of Medical Virology|October 3, 2022
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agentsValentina Mazzotta, Alessandro Cozzi Lepri, Francesca Colavita, et al.
Pageof 11